BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rizwani W, Allen AE, Trevino JG. Hepatocyte Growth Factor from a Clinical Perspective: A Pancreatic Cancer Challenge. Cancers (Basel) 2015;7:1785-805. [PMID: 26404380 DOI: 10.3390/cancers7030861] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Lakkakula BVKS, Farran B, Lakkakula S, Peela S, Yarla NS, Bramhachari PV, Kamal MA, Saddala MS, Nagaraju GP. Small molecule tyrosine kinase inhibitors and pancreatic cancer—Trials and troubles. Seminars in Cancer Biology 2019;56:149-67. [DOI: 10.1016/j.semcancer.2018.09.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
2 Lu W, Li N, Liao F. Identification of Key Genes and Pathways in Pancreatic Cancer Gene Expression Profile by Integrative Analysis. Genes (Basel) 2019;10:E612. [PMID: 31412643 DOI: 10.3390/genes10080612] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
3 Church KJ, Vanderwerff BR, Riggers RR, Mateo-Victoriano B, Fagnan M, Harris PH, LeValley JC, Harding JW. Norleual, a hepatocyte growth factor and macrophage stimulating protein dual antagonist, increases pancreatic cancer sensitivity to gemcitabine. Anticancer Drugs 2018;29:295-306. [PMID: 29389804 DOI: 10.1097/CAD.0000000000000598] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Chen ST, Kuo TC, Liao YY, Lin MC, Tien YW, Huang MC. Silencing of MUC20 suppresses the malignant character of pancreatic ductal adenocarcinoma cells through inhibition of the HGF/MET pathway. Oncogene 2018;37:6041-53. [PMID: 29993037 DOI: 10.1038/s41388-018-0403-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
5 Yang Y, Gu J, Li X, Xue C, Ba L, Gao Y, Zhou J, Bai C, Sun Z, Zhao RC. HIF-1α promotes the migration and invasion of cancer-associated fibroblasts by miR-210. Aging Dis 2021;12:1794-807. [PMID: 34631221 DOI: 10.14336/AD.2021.0315] [Reference Citation Analysis]
6 Modica C, Tortarolo D, Comoglio PM, Basilico C, Vigna E. MET/HGF Co-Targeting in Pancreatic Cancer: A Tool to Provide Insight into the Tumor/Stroma Crosstalk. Int J Mol Sci 2018;19:E3920. [PMID: 30544501 DOI: 10.3390/ijms19123920] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
7 Erdogan B, Webb DJ. Cancer-associated fibroblasts modulate growth factor signaling and extracellular matrix remodeling to regulate tumor metastasis. Biochem Soc Trans 2017;45:229-36. [PMID: 28202677 DOI: 10.1042/BST20160387] [Cited by in Crossref: 175] [Cited by in F6Publishing: 123] [Article Influence: 35.0] [Reference Citation Analysis]
8 Noguchi K, Konno M, Eguchi H, Kawamoto K, Mukai R, Nishida N, Koseki J, Wada H, Akita H, Satoh T, Marubashi S, Nagano H, Doki Y, Mori M, Ishii H. c-Met affects gemcitabine resistance during carcinogenesis in a mouse model of pancreatic cancer. Oncol Lett 2018;16:1892-8. [PMID: 30008881 DOI: 10.3892/ol.2018.8793] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
9 Zhang ZS, Yang RH, Yao X, Cheng YY, Shi HX, Yao CY, Gao ZX, Qi DF, Zhang WK, Dou YY, Guo J, Hu MW, Zhao H, Fang D. HGF/c-MET pathway contributes to cisplatin-mediated PD-L1 expression in hepatocellular carcinoma. Cell Biol Int 2021. [PMID: 34486197 DOI: 10.1002/cbin.11697] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Perales S, Torres C, Jimenez-Luna C, Prados J, Martinez-Galan J, Sanchez-Manas JM, Caba O. Liquid biopsy approach to pancreatic cancer. World J Gastrointest Oncol 2021; 13(10): 1263-1287 [PMID: 34721766 DOI: 10.4251/wjgo.v13.i10.1263] [Reference Citation Analysis]
11 Arias-Pinilla GA, Modjtahedi H. Therapeutic Application of Monoclonal Antibodies in Pancreatic Cancer: Advances, Challenges and Future Opportunities. Cancers (Basel) 2021;13:1781. [PMID: 33917882 DOI: 10.3390/cancers13081781] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Pothula SP, Xu Z, Goldstein D, Pirola RC, Wilson JS, Apte MV. Targeting HGF/c-MET Axis in Pancreatic Cancer. Int J Mol Sci 2020;21:E9170. [PMID: 33271944 DOI: 10.3390/ijms21239170] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
13 Wright JW, Church KJ, Harding JW. Hepatocyte Growth Factor and Macrophage-stimulating Protein "Hinge" Analogs to Treat Pancreatic Cancer. Curr Cancer Drug Targets 2019;19:782-95. [PMID: 30914029 DOI: 10.2174/1568009619666190326130008] [Reference Citation Analysis]
14 Patil K, Khan FB, Akhtar S, Ahmad A, Uddin S. The plasticity of pancreatic cancer stem cells: implications in therapeutic resistance. Cancer Metastasis Rev 2021;40:691-720. [PMID: 34453639 DOI: 10.1007/s10555-021-09979-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Chen C, Wang X, Fang J, Xue J, Xiong X, Huang Y, Hu J, Ling K. EGFR-induced phosphorylation of type Iγ phosphatidylinositol phosphate kinase promotes pancreatic cancer progression. Oncotarget 2017;8:42621-37. [PMID: 28388589 DOI: 10.18632/oncotarget.16730] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
16 Lazzari G, Nicolas V, Matsusaki M, Akashi M, Couvreur P, Mura S. Multicellular spheroid based on a triple co-culture: A novel 3D model to mimic pancreatic tumor complexity. Acta Biomater 2018;78:296-307. [PMID: 30099198 DOI: 10.1016/j.actbio.2018.08.008] [Cited by in Crossref: 111] [Cited by in F6Publishing: 95] [Article Influence: 27.8] [Reference Citation Analysis]